BHP Billiton Limited vs State Street SPDR S&P Biotech ETF — how do they compare? BHP Billiton Limited trades at $85.19 (market cap $205.61B), while State Street SPDR S&P Biotech ETF trades at $155.32. The key difference: BHP Billiton Limited pays a 3.15% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals.
| BHP | XBI | |
|---|---|---|
Market Cap | $205.61B | — |
Sector | Basic Materials | Broad Market / Factor |
52-Week High | $93.15 | $164.28 |
52-Week Low | $50.37 | $85.16 |
Enterprise Value | $219.82B | — |
Dividend Yield | 3.15% | — |
Signals from Pluang's Aura AI — not financial advice
BHP trades at $81.37, down 0.38% with neutral technical signals. The stock shows strong profitability with 18.97% net margin and 20.13% ROE, though recent earnings missed expectations in Q4 2025. Cash flow remains positive with $75M net in 2024, while debt-to-asset ratio increased to 17.65%. Recent news highlights labor strikes and a $2.3B writedown at the Jansen potash project.
Outlook is mixed: solid fundamentals and analyst buy ratings (22.58%) support potential upside, but near-term risks from operational disruptions and cost overruns may pressure shares. Investors should weigh strong cash generation against execution challenges under new leadership.
XBI trades at $155.34, down 2.32% on the day, but maintains a bullish technical outlook with strong momentum indicators. The biotech ETF has gained significant attention after a 17% monthly surge, driven by sector rotation and M&A activity. Analyst coverage remains limited with a single hold rating, though recent news highlights biotech's strong performance amid market volatility.
The ETF offers exposure to biotech's resurgence with AI drug discovery and deal momentum as catalysts. However, high volatility and concentrated sector risk require careful position sizing. Current technical strength suggests potential for continued upside if sector momentum persists.
Trailing returns across standard periods
BHP Group Limited operates as a mining company. The Company engages in the exploration, development, production, and processing of iron ore, metallurgical coal, and copper. BHP Group serves customers worldwide.
Read more on BHP →XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →